Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Han Ng

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
Alimentary Pharmacology & Therapeutics|April 27, 2025
Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 StudyPojsakorn Danpanichkul, Yanfang Pang, Luis Antonio Díaz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 17, 2022
Barriers and Facilitators to Engagement With a Weight Management Intervention in Asian Patients With Overweight or Obesity: A Systematic ReviewVickram Vijay Anand, Ethan Lee Cheng Zhe, Yip Han Chin, et al.
Clinical and Molecular Hepatology|May 19, 2022
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseCheng Han Ng, Kai En Chan, Yip Han Chin, et al.
The American Journal of Gastroenterology|October 3, 2022
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 ParticipantsPhoebe Wen Lin Tay, Cheng Han Ng, Snow Yunni Lin, et al.
Biomedicines|October 27, 2022
Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency AblationBenjamin Wei Rong Tay, Daniel Q Huang, Muthiah Mark, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2023
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metforminRebecca W Zeng, Jie Ning Yong, Darren J H Tan, et al.
Gastro Hep Advances|August 12, 2024
Global Prevalence, Risk Factors, and Outcomes of Depression After Liver Transplant: A Systematic Review and Meta-analysisWen Hui Lim, Chen Wei Poh, Beatrice Jia Min Tan, et al.
Digestive Diseases and Sciences|November 16, 2023
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-AnalysisZhen Yu Wong, Jia Hong Koh, Mark Muthiah, et al.
European Journal of Preventive Cardiology|May 15, 2023
Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviewsClyve Yu Leon Yaow, Bryan Chong, Yip Han Chin, et al.
Metabolism: Clinical and Experimental|June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
Alimentary Pharmacology & Therapeutics|April 27, 2025
Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 StudyPojsakorn Danpanichkul, Yanfang Pang, Luis Antonio Díaz, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 17, 2022
Barriers and Facilitators to Engagement With a Weight Management Intervention in Asian Patients With Overweight or Obesity: A Systematic ReviewVickram Vijay Anand, Ethan Lee Cheng Zhe, Yip Han Chin, et al.
Clinical and Molecular Hepatology|May 19, 2022
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver diseaseCheng Han Ng, Kai En Chan, Yip Han Chin, et al.
The American Journal of Gastroenterology|October 3, 2022
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 ParticipantsPhoebe Wen Lin Tay, Cheng Han Ng, Snow Yunni Lin, et al.
Biomedicines|October 27, 2022
Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency AblationBenjamin Wei Rong Tay, Daniel Q Huang, Muthiah Mark, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2023
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metforminRebecca W Zeng, Jie Ning Yong, Darren J H Tan, et al.
Gastro Hep Advances|August 12, 2024
Global Prevalence, Risk Factors, and Outcomes of Depression After Liver Transplant: A Systematic Review and Meta-analysisWen Hui Lim, Chen Wei Poh, Beatrice Jia Min Tan, et al.
Digestive Diseases and Sciences|November 16, 2023
Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-AnalysisZhen Yu Wong, Jia Hong Koh, Mark Muthiah, et al.
European Journal of Preventive Cardiology|May 15, 2023
Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviewsClyve Yu Leon Yaow, Bryan Chong, Yip Han Chin, et al.
Metabolism: Clinical and Experimental|June 28, 2024
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Pageof 21